Shebli Atrash, M.D. – FDA Inspection, Mar 16, 2023

Record Details

This FDA Inspection record concerns Shebli Atrash, M.D., with an inspection on March 16, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Shebli Atrash, M.D.
Inspection Date: March 16, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Tracy R. Ball

View Company Profile

ID · e9ce8994-73d2-4b6d-b556-8774e907b959

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number: 1201134
FDA center: Human Drugs
Project area: Bioresearch Monitoring

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Shebli Atrash, M.D.

FDA Inspection

Shebli Atrash, M.D.March 16, 2023